167 related articles for article (PubMed ID: 17238204)
21. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories.
Jimenez FA
Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711
[No Abstract] [Full Text] [Related]
22. PDA workshop on "Quality by Design for Biopharmaceuticals: Concepts and Implementation", May 21-22, 2007, Bethesda, Maryland.
Rathore AS; Devine R
PDA J Pharm Sci Technol; 2008; 62(5):380-90. PubMed ID: 19055233
[TBL] [Abstract][Full Text] [Related]
23. Development, validation and transfer of a near infrared method to determine in-line the end point of a fluidised drying process for commercial production batches of an approved oral solid dose pharmaceutical product.
Peinado A; Hammond J; Scott A
J Pharm Biomed Anal; 2011 Jan; 54(1):13-20. PubMed ID: 20801599
[TBL] [Abstract][Full Text] [Related]
24. Drug nanocrystals in the commercial pharmaceutical development process.
Möschwitzer JP
Int J Pharm; 2013 Aug; 453(1):142-56. PubMed ID: 23000841
[TBL] [Abstract][Full Text] [Related]
25. Improving drug manufacturing with process analytical technology.
Rodrigues LO; Alves TP; Cardoso JP; Menezes JC
IDrugs; 2006 Jan; 9(1):44-8. PubMed ID: 16374733
[TBL] [Abstract][Full Text] [Related]
26. [The importance of micronization in the design of dosage forms I. Theoretical and biopharmaceutical aspects].
Antal I
Acta Pharm Hung; 2006; 76(2):95-103. PubMed ID: 17094668
[TBL] [Abstract][Full Text] [Related]
27. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
Giacoia GP; Taylor-Zapata P; Zajicek A
Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
[TBL] [Abstract][Full Text] [Related]
28. Product Quality Research Institute evaluation of cascade impactor profiles of pharmaceutical aerosols. Part 3. Final report on a statistical procedure for determining equivalence.
Christopher D; Adams W; Amann A; Bertha C; Byron PR; Doub W; Dunbar C; Hauck W; Lyapustina S; Mitchell J; Morgan B; Nichols S; Pan Z; Singh GJ; Tougas T; Tsong Y; Wolff R; Wyka B
AAPS PharmSciTech; 2007 Nov; 8(4):E90. PubMed ID: 18181550
[TBL] [Abstract][Full Text] [Related]
29. In vitro - in vivo correlation: from theory to applications.
Emami J
J Pharm Pharm Sci; 2006; 9(2):169-89. PubMed ID: 16959187
[TBL] [Abstract][Full Text] [Related]
30. Process analytical technology and compensating for nonlinear effects in process spectroscopic data for improved process monitoring and control.
Chen Z; Morris J
Biotechnol J; 2009 May; 4(5):610-9. PubMed ID: 19452463
[TBL] [Abstract][Full Text] [Related]
31. Application of imaging based tools for the characterisation of hollow spray dried amorphous dispersion particles.
Gamble JF; Ferreira AP; Tobyn M; DiMemmo L; Martin K; Mathias N; Schild R; Vig B; Baumann JM; Parks S; Ashton M
Int J Pharm; 2014 Apr; 465(1-2):210-7. PubMed ID: 24508807
[TBL] [Abstract][Full Text] [Related]
32. Polymorph selection: the role of nucleation, crystal growth and molecular modeling.
Erdemir D; Lee AY; Myerson AS
Curr Opin Drug Discov Devel; 2007 Nov; 10(6):746-55. PubMed ID: 17987526
[TBL] [Abstract][Full Text] [Related]
33. Particle shape effects on subvisible particle sizing measurements.
Cavicchi RE; Carrier MJ; Cohen JB; Boger S; Montgomery CB; Hu Z; Ripple DC
J Pharm Sci; 2015 Mar; 104(3):971-87. PubMed ID: 25446188
[TBL] [Abstract][Full Text] [Related]
34. Drug safety: the viewpoint of the pharmaceutical manufacturing industry.
Wigle WW
Can Med Assoc J; 1968 Feb; 98(6):314-7. PubMed ID: 5636099
[No Abstract] [Full Text] [Related]
35. Size exclusion chromatography with evaporative light scattering detection as a method for speciation analysis of polydimethylsiloxanes. II. Validation of the method for analysis of pharmaceutical formulations.
Mojsiewicz-Pieńkowska K
J Pharm Biomed Anal; 2011 Dec; 56(4):851-8. PubMed ID: 21840148
[TBL] [Abstract][Full Text] [Related]
36. Particle sizing measurements in pharmaceutical applications: comparison of in-process methods versus off-line methods.
Silva AF; Burggraeve A; Denon Q; Van der Meeren P; Sandler N; Van Den Kerkhof T; Hellings M; Vervaet C; Remon JP; Lopes JA; De Beer T
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1006-18. PubMed ID: 23583493
[TBL] [Abstract][Full Text] [Related]
37. Critical freezing rate in freeze drying nanocrystal dispersions.
Lee J; Cheng Y
J Control Release; 2006 Mar; 111(1-2):185-92. PubMed ID: 16430987
[TBL] [Abstract][Full Text] [Related]
38. Pharmaceutical applications of separation of absorption and scattering in near-infrared spectroscopy (NIRS).
Shi Z; Anderson CA
J Pharm Sci; 2010 Dec; 99(12):4766-83. PubMed ID: 20821396
[TBL] [Abstract][Full Text] [Related]
39. Particle engineering techniques for inhaled biopharmaceuticals.
Shoyele SA; Cawthorne S
Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1009-29. PubMed ID: 17005293
[TBL] [Abstract][Full Text] [Related]
40. Particle design of poorly water-soluble drug substances using supercritical fluid technologies.
Yasuji T; Takeuchi H; Kawashima Y
Adv Drug Deliv Rev; 2008 Feb; 60(3):388-98. PubMed ID: 18068261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
